Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
31
This work is financially supported by the National Key Basic Research Program of China973 projects 2009CB930200;the program of National Natural Science Foundation of China 30970784 and 81171455.The authors are grateful for the support of the Chinese Academy of Sciences CAS ”Hundred Talents Program” and CAS Knowledge Innovation Program
2013-09-04(万方平台首次上网日期,不代表论文的发表时间)
共10页
100-109